New thoughts on sepsis: the unifier of critical care.
In the United States, more than $16 billion annually is spent managing patients with severe sepsis and its sequelae. Insight into the inflammatory response, endothelial tissue, and the coagulation cascade suggest promising new treatment regimens that limit morbidity and mortality due to sepsis and m...
| Publicado en: | Dimensions of Critical Care Nursing Vol. 22; no. 1; pp. 20 - 31 |
|---|---|
| Autores principales: | , |
| Formato: | case study pictorial practice guidelines tables/charts Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Jan/Feb2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106860205&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106860205 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 07304625 48N jtl: Dimensions of Critical Care Nursing issn: 07304625 maglogo: N pubinfo: dt: Jan/Feb2003 vid: 22 iid: 1 pid: 5086 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 106860205 106860205 2003107086 10.1097/00003465-200301000-00004 NLM12548098 106860205 ppf: 20 ppct: 11 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: New thoughts on sepsis: the unifier of critical care. aug: au: Schulman CS Hare K affil: Trauma and Surgery Clinical Nurse Specialist, Harborview Medical Center, Seattle, WA sug: subj: Critical Care Recombinant Proteins Administration and Dosage Recombinant Proteins Therapeutic Use Sepsis Therapy Adult AIDS Patients Blood Coagulation Critical Care Nursing Critically Ill Patients Endothelium Physiology Female Fluid Resuscitation Hematologic Tests Inflammation Inpatients Multiple Organ Dysfunction Syndrome Respiratory Distress Syndrome, Acute Sepsis Diagnosis Sepsis Drug Therapy Sepsis Etiology Sepsis Nursing Sepsis Physiopathology Respiration, Artificial Vital Signs Adult: 19-44 years Female ab: In the United States, more than $16 billion annually is spent managing patients with severe sepsis and its sequelae. Insight into the inflammatory response, endothelial tissue, and the coagulation cascade suggest promising new treatment regimens that limit morbidity and mortality due to sepsis and multisystem organ failure. This article will discuss new information regarding the pathophysiology of the inflammatory response and sepsis. Current thoughts on clinical management and a promising new agent, Activated Protein C, will be presented. pubtype: Academic Journal doctype: case study pictorial practice guidelines tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|